GlassScriptPhysician profile
Mark C Bocchicchio
NPI 1770543373
$5,577.14
in general payments reported to CMS, 2019-2025
23 companies · $853 in 2025
The $853 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $495 · 2020: $386 · 2021: $494 · 2022: $1,509 · 2023: $1,070 · 2024: $769 · 2025: $853.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,407 · Entertainment: $276 · Education: $9.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,407.23 |
| Entertainment | $276.15 |
| Education | $9.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,030.04 | 2021-2024 | Azure Xt Dr Mri Surescan |
| Abbott Laboratories | $1,002.46 | 2019-2024 | Mitraclip, Gallant, Navitor |
| Edwards Lifesciences Corporation | $741.68 | 2020-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Biosense Webster, INC. | $467.36 | 2021-2025 | Carto 3 |
| Impulse Dynamics (USA) INC. | $286.42 | 2022 | |
| Opsens INC. | $276.15 | 2023 | Optowire |
| Medtronic Vascular, INC. | $246.37 | 2019 | |
| Ge Healthcare | $223.61 | 2021-2023 | |
| Boston Scientific Corporation | $184.07 | 2019-2024 | Watchman Flx |
| Abiomed | $183.88 | 2019-2025 | Impella |
| Inari Medical, INC. | $160.42 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Philips North America LLC | $134.65 | 2020-2024 | (Cm9) Amb Mon & Diag Und, (P84) Igt Devices Systems |
| Acell, INC. | $118.86 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $114.70 | 2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $109.44 | 2023 | Camzyos |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $94.60 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $57.11 | 2020 | |
| Bardy Diagnostics, INC. | $36.82 | 2022 | |
| Heartflow, INC. | $33.05 | 2025 | |
| Atricure, INC. | $21.56 | 2024 | |
| Amgen INC. | $20.58 | 2024 | Repatha |
| Pfizer INC. | $17.16 | 2025 | |
| Esperion Therapeutics, INC. | $16.15 | 2025 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Bocchicchio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.